Ceritinib (LDK378)

Ceritinib (LDK378)
Ceritinib (LDK378)
Ceritinib (LDK378)
Ceritinib (LDK378)
Ceritinib (LDK378)

Ceritinib (LDK378)

Min.Order / FOB Price:Get Latest Price

1 Gram

FOB Price: USD 1.0000

  • Min.Order :1 Gram
  • Purity: 99%min.
  • Payment Terms : T/T,

Keywords

Ceritinib LDK378 1032900-25-6

Quick Details

  • Appearance:White to off-white powder
  • Application:Ceritinib was used in patients with anaplastic lymphoma kinase positive (ALK +) metastatic non-small cell lung cancer (NSCLC) after crizotinib intolerance or after treatment of crizotinib with exacerb
  • PackAge:1g/1kg/Al-foiled bag; 25kg/drum
  • ProductionCapacity:10|Kilogram|Month
  • Storage:Room temperature
  • Transportation:By Air,by courier

Superiority:

LIDE PHARMACEUTICALS LIMITED is a professional chemicals and APIs leading manufacturer in China.  Our core business line covers APIs, Intermediates, Herb extract, etc.

 

We are specialized in chemical synthesis, process development of pharmaceutical intermediates, active pharmaceutical ingredients (APIs) and rare chemicals. We also accept custom synthesis project and contract research services.

 

R&D strength:

We have well equipped chemicals and instrumental laboratories with modern instruments such as HPLC,GC,IR,UV,NMR,LC-MS etc.

 

At present, we are selling it with good discount for immediate delivery !  BOOKING TO HASTEN ! 

Details:

(1) Company profile:

Company profile: Lide pharmaceuticals limited

Main products: APIs; Intermediate and other fine chemical products; Piperazine series; Custom Synthesis.

Main Markets: North America; South America; Eastern Europe; Southeast Asia; Africa Oceania; Mid East; Eastern Asia; Western Europe, etc.

 

(2) Product:

Product Name: Ceritinib (LDK378)

CAS No.: 1032900-25-6

Molecular Formula: C28H36ClN5O3S

Molecular Weight: 558.13514

Appearance: White to off-white powder

Specification: 99%Min.

 

(3) Application: 

Ceritinib was used in patients with anaplastic lymphoma kinase positive (ALK +) metastatic non-small cell lung cancer (NSCLC) after crizotinib intolerance or after treatment of crizotinib with exacerbation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

Related Searches

Confirm to collect the product to my collection?

OKCancel

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View